Cargando…

Differentiating central nervous system demyelinating disorders: The role of clinical, laboratory, imaging characteristics and peripheral blood type I interferon activity

Objective: While multiple sclerosis (MS) is considered the cornerstone of autoimmune demyelinating CNS disorders, systemic autoimmune diseases (SADs) are important MS mimickers. We sought to explore whether distinct clinical, laboratory, and imaging characteristics along with quantitation of periphe...

Descripción completa

Detalles Bibliográficos
Autores principales:	Karathanasis, Dimitris K., Rapti, Anna, Nezos, Adrianos, Skarlis, Charalampos, Kilidireas, Constantinos, Mavragani, Clio P., Evangelopoulos, Maria Eleftheria
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9412761/ https://www.ncbi.nlm.nih.gov/pubmed/36034800 http://dx.doi.org/10.3389/fphar.2022.898049

Ejemplares similares

Milk Fat Globule Epidermal Growth Factor 8 (MFGE8) Gene Variants in Rheumatoid Arthritis and Sjögren’s Syndrome
por: Skarlis, Charalampos, et al.
Publicado: (2022)

The role of type I IFN in autoimmune and autoinflammatory diseases with CNS involvement
por: Raftopoulou, Sylvia, et al.
Publicado: (2022)

Editorial: Demyelinating neurological syndromes: The role of autoimmunity
por: Evangelopoulos, Maria Eleftheria, et al.
Publicado: (2023)

+3179G/A Insulin-Like Growth Factor-1 Receptor Polymorphism: A Novel Susceptibility Contributor in Anti-Ro/SSA Positive Patients with Sjögren’s Syndrome: Potential Clinical and Pathogenetic Implications
por: Skarlis, Charalampos, et al.
Publicado: (2021)

Contribution of Genetic Factors to Sjögren's Syndrome and Sjögren's Syndrome Related Lymphomagenesis
por: Nezos, Adrianos, et al.
Publicado: (2015)

Study of the incidence of osteoporosis in patients with Sjögren’s syndrome (pSS) and investigation of activation of the RANKL /RANK and osteoprotegerin (OPG) system
por: Skarlis, Charalampos, et al.
Publicado: (2018)

Central Nervous System Demyelination in a Charcot-Marie-Tooth Type 1A Patient
por: Koros, Christos, et al.
Publicado: (2013)

B-cell Activating Factor Polymorphisms in Rheumatoid Arthritis-Associated Atherosclerosis
por: Kintrilis, Nikolaos, et al.
Publicado: (2021)

Association Between DNA Damage Response, Fibrosis and Type I Interferon Signature in Systemic Sclerosis
por: Vlachogiannis, Nikolaos I., et al.
Publicado: (2020)

Sjogren’s Syndrome: Recent Updates
por: Skarlis, Charalampos, et al.
Publicado: (2022)

Osteoprotegerin and MTHFR gene variations in rheumatoid arthritis: association with disease susceptibility and markers of subclinical atherosclerosis
por: Arida, Aikaterini, et al.
Publicado: (2022)

Lipoprotein-Associated Phospholipase A2: A Novel Contributor in Sjögren’s Syndrome-Related Lymphoma?
por: Nezos, Adrianos, et al.
Publicado: (2021)

Hematological Abnormalities in COVID-19 Disease: Association With Type I Interferon Pathway Activation and Disease Outcomes
por: Georgakopoulou, Vasiliki E., et al.
Publicado: (2022)

TNFAIP3 F127C Coding Variation in Greek Primary Sjogren's Syndrome Patients
por: Nezos, Adrianos, et al.
Publicado: (2018)

The Role of Novel Autoantibodies in the Diagnostic Approach and Prognosis of Patients with Raynaud’s Phenomenon
por: Koulouri, Vasiliki, et al.
Publicado: (2020)

Specific myeloid signatures in peripheral blood differentiate active and rare clinical phenotypes of multiple sclerosis
por: Vakrakou, Aigli G., et al.
Publicado: (2023)

The Role of Myositis-Specific and Myositis-Associated Autoantibodies and the Activation of Type I Interferon Pathway in the Generation of Clinical Phenotypes of Inflammatory Myopathies
por: Skarlis, Charalampos, et al.
Publicado: (2023)

Atherosclerosis in SLE: a potential role for serum parathormone levels
por: Giannelou, Mayra, et al.
Publicado: (2020)

Leukocyte Immunoglobulin-Like Receptor A3 (LILRA3): A Novel Marker for Lymphoma Development among Patients with Young Onset Sjogren’s Syndrome
por: Argyriou, Evangelia, et al.
Publicado: (2021)

Distinct type I interferon responses between younger women and older men contribute to the variability of COVID-19 outcomes: Hypothesis generating insights from COVID-19 convalescent individuals
por: Mavragani, Clio P., et al.
Publicado: (2022)

Potential Role of Antibodies against Aquaporin-1 in Patients with Central Nervous System Demyelination
por: Pechlivanidou, Maria, et al.
Publicado: (2023)

Effective DNA damage response after acute but not chronic immune challenge: SARS-CoV-2 vaccine versus Systemic Lupus Erythematosus
por: Ntouros, Panagiotis A., et al.
Publicado: (2021)

Subclinical atherosclerosis and impaired bone health in patients with primary Sjogren’s syndrome: prevalence, clinical and laboratory associations
por: Gravani, Fotini, et al.
Publicado: (2015)

HCV-Related Central and Peripheral Nervous System Demyelinating Disorders
por: Mariotto, Sara, et al.
Publicado: (2014)

Moyamoya Disease May Mimic Multiple Sclerosis?
por: Spanou, Ioanna, et al.
Publicado: (2019)

Demyelinating diseases of the central nervous system registry for patients with traditional Chinese medicine: Rationale and design of a prospective, multicenter, observational study
por: Liu, Jia, et al.
Publicado: (2022)

Demyelinating Disease following Anti-TNFa Treatment: A Causal or Coincidental Association? Report of Four Cases and Review of the Literature
por: Andreadou, E., et al.
Publicado: (2013)

Central and peripheral demyelination
por: Mehndiratta, Man Mohan, et al.
Publicado: (2014)

Immunopathology of Tumefactive Demyelinating Lesions-From Idiopathic to Drug-Related Cases
por: Vakrakou, Aigli G., et al.
Publicado: (2022)

Demyelinating Disorders of the Central Nervous System
por: Pirko, Istvan, et al.
Publicado: (2007)

Clinico-radiologic features and therapeutic strategies in tumefactive demyelination: a retrospective analysis of 50 consecutive cases
por: Vakrakou, Aigli G., et al.
Publicado: (2021)

Activation of Type I Interferon Pathway in Systemic Lupus Erythematosus: Association with Distinct Clinical Phenotypes
por: Karageorgas, Theophanis P., et al.
Publicado: (2011)

MTHFR gene variants and non-MALT lymphoma development in primary Sjogren’s syndrome
por: Fragkioudaki, Sofia, et al.
Publicado: (2017)

Recurrent Fulminant Tumefactive Demyelination With Marburg-Like Features and Atypical Presentation: Therapeutic Dilemmas and Review of Literature
por: Vakrakou, Aigli G., et al.
Publicado: (2020)

Combined central and peripheral demyelination
por: Menon, Bindu, et al.
Publicado: (2014)

Musculoskeletal Manifestations in Sjogren’s Syndrome: An Orthopedic Point of View
por: Rozis, Meletios, et al.
Publicado: (2021)

Inflammatory demyelinating diseases of the central nervous system
por: Höftberger, Romana, et al.
Publicado: (2018)

Glia from the central and peripheral nervous system are differentially affected by paclitaxel chemotherapy via modulating their neuroinflammatory and neuroregenerative properties
por: Klein, Ines, et al.
Publicado: (2022)

Combined peripheral and central nervous system demyelination post-COVID-19 vaccination: A case report.
por: AlKolfat, Fatma, et al.
Publicado: (2022)

Central nervous system inflammatory demyelinating disorders of childhood
por: Kamate, Mahesh, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_9slils1393q2nm6kqi48db34u4